Navigation Links
National Jewish Health researchers awarded $13 million to evaluate treatments for toxic gases
Date:10/13/2011

National Jewish Health researchers have received nearly $13 million from the National Institutes of Health to evaluate potential rescue medications for victims of terrorist attacks, wartime use of toxic gases, and/or inhalation disasters. The gases of greatest interest in these studies will be 'mustard gas' (sulfur mustard) and chlorine gas.

"The excitement about these studies is that they are designed to provide rescue treatments," said Carl White, MD, principal investigator of the grant.

The grant, part of the NIH's Countermeasures Against Chemical Threats Research Network (CounterACT), is for 5 years. The rescue agents to be given greatest study in these trials will include fibrinolytics ('clot busters'), anticoagulants, catalytic antioxidants, and flavonoids (specific herbal remedies). Researchers will evaluate models of damage to the lungs and airways and to skin.

"We have already found very encouraging preliminary data in which some of our agents can be effective even when given several hours after the toxic inhalation," said Dr. White. "This is important because real world conditions can cause minutes to hours of delay in getting to victims of such tragedies."

The work involves collaborations between two teams of investigators at National Jewish Health and one from the University of Colorado School of Pharmacy, as well as a collaborating center at the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD).

"The drugs we are testing work through several different mechanisms so that they may prevent or limit progressive damage to airways or skin, as well as prevent or clear blockage of airways," said Dr. White. "It is also exciting that some of the treatments we develop may also carry over to other difficult lung diseases of childhood and adults."

The initial focus of the research is on the acute injury to lungs and skin occurring in the first 24-48 hours of exposure. As the studies progress over the next several years, researchers hope to evaluate the ability of our relatively early interventions to prevent lung fibrosis and bronchiolitis obliterans that can result from such exposures.


'/>"/>
Contact: William Allstetter
allstetterw@njhealth.org
303-398-1002
National Jewish Health
Source:Eurekalert

Related medicine news :

1. NationalCreditReport.com Reminds Consumers of Ways to Improve Credit Report and Score in 2010
2. The National Coalition for Cancer Survivorship Joins the Commission on Cancer
3. National Wildlife Federation Says Outdoor Time for Kids Can Help First Lady Achieve Her “Let's Move” Goal
4. Howard Dean to Speak at the 2010 DTC National Conference
5. International Diabetes Federation awards $2 million to 9 global diabetes research projects
6. Jion Beijing Great Wall International Travel Agency Immediate Exposure to China Expo 2010
7. U.S. National Guard Connects Nationwide with Desktop Alert's Command and Control Mass Notification Systems and Common Alerting Protocol (CAP)
8. H1N1 international symposium to be hosted by Emory-UGA Influenza Center
9. The Alliance for a Healthier Generation Names Celtics Captain Paul Pierce National Athlete Spokesperson in the Fight Against Childhood Obesity
10. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
11. Protecting patients: Study shows that Johns Hopkins flu vaccination rates twice national average
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Global MEMS Devices Medical Market Analysis 2016 - Forecast to ... The report contains up to date financial ... reliable analysis. Assessment of major trends with potential impact on ... dive analysis of market segmentation which comprises of sub markets, ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
Breaking Medicine Technology: